Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis.

Authors:
Zhang JB; Zhang QR; Jin Q; Yang J; Lin SZ and 1 more

Journal:
Mol Metab

Publication Year: 2023

DOI:
10.1016/j.molmet.2023.101865

PMCID:
PMC10825057

PMID:
38163459

Journal Information

Full Title: Mol Metab

Abbreviation: Mol Metab

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding This work was financially supported by grants from the 10.13039/501100001809National Natural Science Foundation of China (No: 82170593) to Jian-Gao Fan."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025